These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1674070)

  • 41. [Prognosis of patients with breast cancer related to the timing of operation during menstrual cycle: a report of 218 patients].
    Zhang B; Shao Y; Wang C
    Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):203-7. PubMed ID: 9387255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The extent of the surgical intervention and the prognosis of patients with stage III breast cancer].
    Adamian AT; Slonimskaia EM; Pushkarev SV
    Vopr Onkol; 1989; 35(6):699-703. PubMed ID: 2750083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma.
    Pujol P; Daures JP; Brouillet JP; Chang S; Rouanet P; Bringer J; Grenier J; Maudelonde T
    Cancer; 2001 May; 91(10):1854-61. PubMed ID: 11346866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases.
    Saad Z; Bramwell VH; Wilson SM; O'Malley FP; Jeacock J; Chambers AF
    Lancet; 1998 Apr; 351(9110):1170-3. PubMed ID: 9643688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer.
    Camoriano JK; Loprinzi CL; Ingle JN; Therneau TM; Krook JE; Veeder MH
    J Clin Oncol; 1990 Aug; 8(8):1327-34. PubMed ID: 2199619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparative study of subcutaneous mastectomy with radical mastectomy.
    Horiguchi J; Iino JHY ; Takei H; Koibuchi Y; Iijima K; Ikeda F; Ochiai R; Uchida K; Yoshida M; Yokoe T; Morishita Y
    Anticancer Res; 2001; 21(4B):2963-7. PubMed ID: 11712794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of the size of nodal metastases on recurrence risk in breast cancer patients with 1-3 positive axillary nodes after mastectomy.
    Harris EE; Freilich J; Lin HY; Chuong M; Acs G
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):609-14. PubMed ID: 22867892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status.
    Yang PS; Chen CM; Liu MC; Jian JM; Horng CF; Liu MJ; Yu BL; Lee MY; Chi CW
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):516-22. PubMed ID: 19577858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum progesterone and prognosis in operable breast cancer.
    Mohr PE; Wang DY; Gregory WM; Richards MA; Fentiman IS
    Br J Cancer; 1996 Jun; 73(12):1552-5. PubMed ID: 8664128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study.
    Rivkin SE; Green S; Metch B; Glucksberg H; Gad-el-Mawla N; Constanzi JJ; Hoogstraten B; Athens J; Maloney T; Osborne CK
    J Clin Oncol; 1989 Sep; 7(9):1229-38. PubMed ID: 2671283
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial.
    Richards MA; O'Reilly SM; Howell A; George WD; Fentiman IS; Chaudary MA; Crowther D; Rubens RD
    J Clin Oncol; 1990 Dec; 8(12):2032-9. PubMed ID: 2230895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of correlation between timing of surgery in relation to the menstrual cycle and prognosis of premenopausal patients with early breast cancer.
    Nomura Y; Kataoka A; Tsutsui S; Murakami S; Takenaka Y
    Eur J Cancer; 1999 Sep; 35(9):1326-30. PubMed ID: 10658522
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estrogen receptor protein of breast cancer as a predictor of recurrence.
    Butler JA; Bretsky S; Menendez-Botet C; Kinne DW
    Cancer; 1985 Mar; 55(6):1178-81. PubMed ID: 3971291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Timing of surgery related to menstrual cycle and prognosis of premenopausal women with breast cancer.
    Mondini G; Decian F; Sorice G; Friedman D; Spirito C; Costantini M; Sormani MP; Civalleri D
    Anticancer Res; 1997; 17(1B):787-90. PubMed ID: 9066621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Menstrual timing of treatment for breast cancer.
    Senie RT; Kinne DW
    J Natl Cancer Inst Monogr; 1994; (16):85-90. PubMed ID: 7999475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up.
    Quiet CA; Ferguson DJ; Weichselbaum RR; Hellman S
    J Clin Oncol; 1995 May; 13(5):1144-51. PubMed ID: 7738620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of primary breast cancer without mastectomy. The Los Angeles community experience and review of the literature.
    Ann Surg; 1986 Aug; 204(2):136-47. PubMed ID: 3741005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.